Successful treatment of thalidomide for recurrent bleeding due to gastric angiodysplasia in hereditary hemorrhagic telangiectasia.

Abstract

Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disorder, which is uncommon anomaly to recurrent gastrointestinal bleeding. Although there are several forms of therapy ranging from local therapy to operations or drug therapy, there is a lack of more effective treatment for the disease. In this report, we presented a Chinese patient with recurrent melena due to gastric angiodysplasia in HHT treated successfully with thalidomide.

• Authors: X-Y Wang, Y Chen, Q Du
• Journal: European review for medical and pharmacological sciences (Eur Rev Med Pharmacol Sci) Vol. 17 Issue 8 Pg. 1114-6 (Apr 2013) ISSN: 1128-3602 [Print] Italy
• PMID: 23661527 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Thalidomide

Topics

• Aged
• Angiodysplasia (complications)
• Gastrointestinal Hemorrhage (drug therapy, etiology)
• Humans
• Male
• Recurrence
• Stomach Diseases (complications)
• Telangiectasia, Hereditary Hemorrhagic (drug therapy)
• Thalidomide (therapeutic use)